Consultant to Biopharma
Simon Fricker is currently working as an independent consultant to small and start-up biopharma companies where he offers valuable experience to drug research and development programs. He was formerly a Principal Scientist in the Biomedical Technology Group of Johnson Matthey, UK (1983–1996); and subsequently Director, Biology at AnorMED, Canada (1996–2006) followed by a Distinguished Scientific Fellow at Genzyme Corp, USA, (2006–2015). His research interests include metal-based drugs, and chemokine receptor biology.
Dr Fricker carried out postdoctoral research at the Medical Research Council (MRC) Biochemical Parasitology Unit, Molteno Institute, University of Cambridge, UK, and the Department of Biochemistry, University of Southampton, UK. He obtained his PhD from the Department of Chemistry and Molecular Sciences, University of Warwick, UK, in 1981, where he conducted graduate work on the effect of cytotoxic anticancer drugs on the DNA metabolism and proliferation of lymphoblasts. He received a BSc (Hons) in Physiology and Biochemistry from the University of Southampton (1976) and an MSc in Molecular Enzymology from the University of Warwick, UK (1978).